Skip to content

Clinical trials

Phase 3 Osteoarthritis, Knee trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoarthritis, Knee Phase: Phase 3 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20174
20181
20212
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed4
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guang'anmen Hospital of China Academy of Chinese Medical Sciences3
Shanghai University of Traditional Chinese Medicine2
Amzell1
Chengdu University of Traditional Chinese Medicine1
Fujian Shengdi Pharmaceutical Co., Ltd.1
Hangzhou Sciwind Biosciences Co., Ltd.1
Hebei Medical University Third Hospital1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
Jiangsu XinChen-Techfields Pharma Co., LTD.1
Shanghai IxCell Biotechnology Co., LTD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoarthritis, Knee14
Obesity1
Osteoarthritis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.